Skip to content

Dr. Steven Schepers

Active
Private limited companyfounded 2011active for 14 yearsKleinstraat 141, 3500 Hasselt, BelgiumKBO/BCE: BE 0841.436.891

From the official registers: KBO 14 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

Dr. Steven Schepers has been active since 2011 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.9m and a net result of €511,953. Equity has been growing by about 19% per year since 2018. Its solvency ranks better than 87% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

KBO
Status
Active since 30-11-2011 Normal situation
Activity
Specialist medical practice NACE 86220
Establishment unit
2.205.177.214 3500 Hasselt, since 30-11-2011
Financial year end
31 December
Peppol
Reachable since 18-03-2025

Board and ownership

Financial position

98 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€469,416
▲ 11.4%
Turnover
≈ €720,000
estimated
Profit
€511,953
▲ 58.6%
Equity
€1.9m
▲ 20.5%
Total assets
€2.0m
▲ 24.9%
Filed on 30-06-2026, 31 days before the deadlineat the National Bank
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 12.40, cash €627,758Figures for financial year 2025 (filed on 30-06-2026)Size: total assets €2.0mShow the evidence

Checked score

Score 2025
98 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 85% of small companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 91.9% of total assets
Liquidity 89+28
short-term debt 8.0% · cash 30.9%
Profitability 100+13
return on assets 25.2%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (1,078 companies, NACE 86, small)
Last 24 months 11-2024: < 0.1% 12-2024: < 0.1%● unchanged vs 11-2024 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: 0.1%▲ +0.1 percentage points vs 08-2026highest value 10-2026: < 0.1%▼ -0.1 percentage points vs 09-2026lowest value
Credit of up to €180,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 12.4 (20.5 in 2024), above the usual 1.5. Short-term debt is 8% and cash 30.9% of total assets. 8.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, small). It does better than 77% of them on solvency, 82% on liquidity, 98% on profitability and 82% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 12.40, cash €627,758
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 30-06-2026)
NBB · annual accounts
lowers risk · Size: total assets €2.0m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 30-06-2026, 31 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
31 days early
2024
37 days early
2023
44 days early
2022
40 days early
2021
34 days early
2020
46 days early
2019
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 39 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 24 June (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 95% of companies in human healthsector median €60,139 · 20,665 companies €511,953 View
  • Positive: Result rose in 2025from €322,849 to €511,953 ▲ 58.6% View
  • Positive: Filed on time since financial year 2018accounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €511,953 8 years View

Comparable companies

These companies have the same main activity as Dr. Steven Schepers: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €1.9m and €2.3m, founded between 2010 and 2012.

CompanyTotal assetsGross margin
Dr. Steven Schepers Hasselt€2.0m€0.5m
DOKTER TOM MULLENERS Heusden-Zolder€2.3m€0.5m
BVBA Dr. Everhard Vandervliet Antwerpen€2.0m€0.5m
Dokter Van Hecke Lien, dermatologe Oudenaarde€2.0m€0.5m
Docteurs CATTEAU et LEJEUNE Merbes-le-Château€2.0m€0.4m
Dokter Jeroen Dockx MKA Zwevegem€1.9m€0.5m
DR. TIM WEYN Wijnegem€2.2m€0.5m
Full comparison

Documents

Annual accounts at the NBB

All 14 annual accounts

Articles and registers

Key facts about Dr. Steven Schepers

What is the company number of Dr. Steven Schepers?
The company number of Dr. Steven Schepers is 0841.436.891. The VAT number is the same number with BE in front: BE 0841.436.891.
Where is Dr. Steven Schepers based?
The registered office is at Kleinstraat 141, 3500 Hasselt.Company details
What does Dr. Steven Schepers do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Steven Schepers?
The legal form of Dr. Steven Schepers is Private limited company (BV).
When was Dr. Steven Schepers founded?
Dr. Steven Schepers was founded on 30-11-2011.
Is Dr. Steven Schepers still active?
Yes, Dr. Steven Schepers is an active enterprise in the KBO register.
What is the turnover of Dr. Steven Schepers?
The turnover in financial year 2025 is ≈ €720,000. This figure is estimated from the gross margin of €469,416 and 36 comparable companies (NACE 862). It probably lies between €650,000 and €910,000.Financials
Is Dr. Steven Schepers profitable?
In financial year 2025, Dr. Steven Schepers made a profit of €511,953.
Where can I find the annual accounts of Dr. Steven Schepers?
Dr. Steven Schepers filed 14 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of Dr. Steven Schepers due?
Dr. Steven Schepers must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.